US Stock MarketDetailed Quotes

IPA ImmunoPrecise Antibodies

Watchlist
  • 0.403
  • +0.003+0.79%
Close Dec 13 16:00 ET
  • 0.410
  • +0.007+1.67%
Post 20:01 ET
11.63MMarket Cap-0.54P/E (TTM)

ImmunoPrecise Antibodies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ImmunoPrecise Antibodies Q2 2025 Earnings Date

Currency：CADDec 10, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
6.44M
6.13M
-314.00K
Miss Est.
+4.70%
-0.41%
-4.88%
EPS
-0.10
-0.09
+<0.01
Beat Est.
+5.19%
+10.00%
+7.02%
Analyst Rating
No Data

ImmunoPrecise Antibodies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 7.090M--
--2025/Q3-- / 6.970M--
Dec 10, 20242025/Q26.125M / 6.439M--
Sep 16, 20242025/Q15.263M / 6.750M--
Jul 29, 20242024/Q46.459M / 6.530M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 7.090M--
--2025/Q3-- / 6.970M--
Dec 10, 20242025/Q26.125M / 6.439M--
Sep 16, 20242025/Q15.263M / 6.750M--
Jul 29, 20242024/Q46.459M / 6.530M--

Unlock Free Earnings Estimates

ImmunoPrecise Antibodies Earnings Reports

  • ImmunoPrecise Antibodies | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

    Dec 10 21:39

  • ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 10 21:39

  • ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 10 21:35

  • ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

    Dec 3 21:36

    • Read more

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data